News zum Sektor Gesundheit aus Polen

 

Ventral AI brings advanced physical world AI capabilities to Voxel's operational intelligence platform SAN FRANCISCO, Oct. 13, 2026 /PRNewswire/ -- Voxel, the industrial intelligence company reenvisioning how real-world work gets done, today announced the addition of Ventral AI, an......

Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...

Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...

Welcomes Hal Mady as Chief Revenue Officer, Krishna Gopalakrishnan as Vice President of Perception and AI, and Asaf Elani as Field Chief Technology Officer. SAN FRANCISCO, Sept. 10, 2026 /PRNewswire/ -- Voxel, the industrial intelligence company reenvisioning how real-world work gets......

Bloom Energy, Everpure und Illumina steigen in den SP 500 auf – Cheniere geht leer aus!Der Indexanbieter SP Dow Jones Indices nimmt im Zuge der vierteljährlichen Neugewichtung drei Werte in den SP 500 auf: den Brennstoffzellen-Spezialisten Bloom ......

Hi3D V3.0, das erste kommerziell erhältliche KI-3D-Modell mit einer Voxel-Auflösung von 2048³, startet mit 48 Stunden kostenlosem Zugang für alle...

BEIJING, Aug. 18, 2026 /PRNewswire/ -- Hi3D, the all-in-one AI 3D creation platform, announces the launch of Hi3D V3.0, the first commercially available AI 3D model with 2048³ voxel resolution. Dramatically reducing the manual mesh repair needed before a model enters the production......

BEIJING, Aug. 14, 2026 /PRNewswire/ -- Hi3D will launch V3.0 on August 19, 2026, with free access to the new model for its first 48 hours on the Hi3D platform. Hi3D V3.0 is the highest-precision AI 3D model today, reaching 2048³ voxel resolution and preserving fine detail across every......

Der DAX nimmt erneut das Rekordhoch ins Visier. Sinkende Ölpreise liefern Schub. Der Leitindex gewinnt 0,3 % und schließt bei 26.391 Punkten. Der EuroStoxx50 steigt 0,4 % auf 6.559 Punkte. Der Iran-Krieg bleibt jedoch das zentrale Risiko. Die Wall Street startet verhalten. Rocket Lab verliert rund 4 %. Hohe Ausbaukosten drücken die erwarteten Margen. Hims & Hers fällt rund 2 %. Ein überraschender Quartalsverlust belastet den Telemedizinanbieter. Gespräche zwischen Oman und Iran wecken Hoffnung für die Straße von Hormus. Brent sinkt auf 87,00 US-Dollar. WTI kostet 81,56 US-Dollar. PNE bricht um 19,5 % ein. Zweifel am Unternehmensverkauf vertreiben die Übernahmefantasie. OHB steigt am Donnerstag für Klöckner & Co. in den SDAX auf. Vier Interviews liefern Orientierung. TAG-Co-CEO Martin Thiel erklärt Polens Wohnungsbau und den ROBYG-Börsengang. ATOSS-CFO Christof Leiber spricht über Wachstum und das starke erste Halbjahr. Heiko Thieme warnt vor bösen Sommergewittern. Rückschläge bleiben für...

WOIPPY, France--(BUSINESS WIRE)--Regulatory News: ABL Diagnostics (Paris:ABLD) announces that its main shareholder, Advanced Biological Laboratories (ABL), a Luxembourg-based diagnostics company, has filed information with the French Financial Markets Authority (AMF) via ONDE, the centralized information filing system, regarding the sale of a new block of ABL Diagnostics shares as part of an over-the-counter transaction with a private third party. The filing relating to this sale can be viewed in the AMF's database of decisions and financial information (BDIF) at the following address: https://bdif.amf-france.org/fr/details/2026DD1129675. With the support of its main shareholder, ABL, ABL Diagnostics is continuing its efforts to enhance its visibility among all stakeholders (investors, partners, customers, and employees). About ABL Diagnostics (ABLD) ABL Diagnostics (ABLD) is an international company that specializes in innovative molecular biology tests and global solutions for its customers: Molecular ...

Poland and Romania's legal battles with Pfizer Inc. over unused Covid-19 vaccine purchases are spilling into the funding of the eastern European nations' air traffic agencies....

WOIPPY, France--(BUSINESS WIRE)--Regulatory News: ABL Diagnostics (Paris:ABLD) announces that its main shareholder, Advanced Biological Laboratories (ABL), a Luxembourg-based diagnostics company, has filed information with the French Financial Markets Authority (AMF) via ONDE, the centralized information filing system, regarding the sale of a new block of ABL Diagnostics shares as part of an over-the-counter transaction with a private third party. The filing relating to this sale can be viewed in the AMF's database of decisions and financial information (BDIF) at the following address: https://bdif.amf-france.org/fr/details/2026DD1125268. With the support of its main shareholder, ABL, ABL Diagnostics is continuing its efforts to enhance its visibility among all stakeholders (investors, partners, customers, and employees). About ABL Diagnostics (ABLD) ABL Diagnostics (ABLD) is an international company that specializes in innovative molecular biology tests and global solutions for its customers: Molecular ...

Poland plans to raise 18 billion zloty ($4.8 billion) over the next decade from higher excise duty on alcohol as the government is searching for new sources of funding for the strained public healthcare system, according to the Finance Ministry....

WOIPPY, France--(BUSINESS WIRE)--Regulatory News: ABL Diagnostics (Paris:ABLD) announces that its main shareholder, Advanced Biological Laboratories (ABL), a Luxembourg-based diagnostics company, has filed information with the French Financial Markets Authority (AMF) via ONDE, the centralized information filing system, regarding the sale of a new block of ABL Diagnostics shares as part of an over-the-counter transaction with a private third party. The filing relating to this sale can be viewed in the AMF's database of decisions and financial information (BDIF) at the following address: https://bdif.amf-france.org/fr/details/2026DD1118776. With the support of its main shareholder, ABL, ABL Diagnostics is continuing its efforts to enhance its visibility among all stakeholders (investors, partners, customers, and employees). About ABL Diagnostics (ABLD) ABL Diagnostics (ABLD) is an international company that specializes in innovative molecular biology tests and global solutions for its customers: Molecular ...

WOIPPY, France--(BUSINESS WIRE)--Regulatory News: ABL Diagnostics (Paris:ABLD) announces that its main shareholder, Advanced Biological Laboratories (ABL), a Luxembourg-based diagnostics company, has filed information with the French Financial Markets Authority (AMF) via ONDE, the centralized information filing system, regarding the sale of a new block of ABL Diagnostics shares as part of an over-the-counter transaction with a private third party. The filing relating to this sale can be viewed in the AMF's database of decisions and financial information (BDIF) at the following address: https://bdif.amf-france.org/fr/details/2026DD1117613. With the support of its main shareholder, ABL, ABL Diagnostics is continuing its efforts to enhance its visibility among all stakeholders (investors, partners, customers, and employees). About ABL Diagnostics (ABLD) ABL Diagnostics (ABLD) is an international company that specializes in innovative molecular biology tests and global solutions for its customers: Molecular ...

KRAKÓW, Poland, May 21, 2026 /PRNewswire/ -- Selvita S.A. (WSE: SLV), one of the leading Drug Discovery and Development organizations in Europe, has published its financial results for Q1 2026 and latest backlog. The Company has decided to launch a strategic options review for the Group's......

Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...

Poland and Romania have been ordered by a Belgian court to pay Pfizer Inc. €1.9 billion ($2.2 billion) for Covid-19 vaccines the two countries refused to take delivery of during the pandemic, handing a win to the drug maker's efforts to enforce the contract....

WOIPPY, France--(BUSINESS WIRE)--Regulatory News: ABL Diagnostics (Paris:ABLD) announces that its main shareholder, Advanced Biological Laboratories (ABL), a Luxembourg-based diagnostics company, has filed information with the French Financial Markets Authority (AMF) via ONDE, the centralized information filing system, regarding the sale of a new block of ABL Diagnostics shares as part of an over-the-counter transaction with a private third party. The filing relating to this sale can be viewed in the AMF's database of decisions and financial information (BDIF) at the following address: https://bdif.amf-france.org/fr/details/2026DD1100972. With the support of its main shareholder, ABL, ABL Diagnostics is continuing its efforts to enhance its visibility among all stakeholders (investors, partners, customers, and employees). About ABL Diagnostics (ABLD) ABL Diagnostics (ABLD) is an international company that specializes in innovative molecular biology tests and global solutions for its customers: Molecular ...

WOIPPY, France--(BUSINESS WIRE)--Regulatory News: ABL Diagnostics (Paris:ABLD) announces that its main shareholder, Advanced Biological Laboratories (ABL), a Luxembourg-based diagnostics company, has filed information with the French Financial Markets Authority (AMF) via ONDE, the centralized information filing system, regarding the sale of a new block of ABL Diagnostics shares as part of an over-the-counter transaction with a private third party. The filing relating to this sale can be viewed in the AMF's database of decisions and financial information (BDIF) at the following address: https://bdif.amf-france.org/fr/details/2026DD1092130. With the support of its main shareholder, ABL, ABL Diagnostics is continuing its efforts to enhance its visibility among all stakeholders (investors, partners, customers, and employees). About ABL Diagnostics (ABLD) ABL Diagnostics (ABLD) is an international company that specializes in innovative molecular biology tests and global solutions for its customers: Molecular ...